Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis.
Comparative Efficacy of Acupuncture Combined With Chinese Herbal Cream and Acupuncture Combined With Calcipotriol for Plaque Psoriasis.
1 other identifier
interventional
28
1 country
1
Brief Summary
Clinical trial which compares 2 treatment methods (1) Acupunture with a Chinese Herbal Cream and (2) Acupuncture with the standard treatment "calcipotriol" for patients with plaque psoriasis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Feb 2026
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 8, 2026
CompletedStudy Start
First participant enrolled
February 9, 2026
CompletedFirst Posted
Study publicly available on registry
February 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 8, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 8, 2027
February 13, 2026
February 1, 2026
12 months
February 8, 2026
February 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Psoriasis Area and Severity Index, PASI score
8 weeks
Secondary Outcomes (1)
Dermatology Life Quality Index (DLQI)
8 weeks
Study Arms (2)
Acupucture + Calcipotriol
ACTIVE COMPARATORParticipant will receive 1 Acupuncture session per week for 8 weeks. And also receive Calcipotriol cream.
Acupuncture + Chinese Herbal Cream
EXPERIMENTALParticipant will receive 1 Acupuncture session per week for 8 weeks. And also receive Chinese Herbal cream.
Interventions
Bai-Hui (GV20), Fei-Shu (BL13), Ge-Shu (BL-17), Qu-Chi (LI11), Zu-San-Li (ST36), He-Gu (LI4), Tai-Chong (LR3), San-Yin-Jiao (SP6), Wei-Zhong (BL40)
Main API : Sophora flavescens Ait. (Ku-Shen), Cnidium monnieri (L.) Cuss. (She-Chuang-Zi), Prunus mume (Sieb.) Sieb.et Zucc. (Wu-Mei), Dictamnus dasycarpus Turcz. (Bai-Xian-Pi), Rheum palmatum L. (Da-Huang)
Eligibility Criteria
You may qualify if:
- Plaque psoriasis on skin, scalp, or nails
- Not receive any psoriasis treatment at least 4 weeks prior to the study
- ≤10% body surface area (BSA), PASI≤10, DLQI≤10
You may not qualify if:
- Pregnancy and lactation
- Other type of psoriasis i.e. Psoriatic arthritis, Pustular psoriasis, Erythrodermic psoriasis
- Uncontrollable diseases i.e. CVS, liver, kidney, cancer
- Using anticoagulants i.e. Aspirin, Warfarin, Clopidogrel, Dabigatran, Riavaraxaban, Apixaban, Heparin
- Treated with psoriasis biologic agents in the past 6 months
- Needle phobia
- Receiving immunosuppresive agents i.e. systemic corticosteroid, NSAIDs, chemotherapeutic agents
- Participating in other clinical study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mae Fah Luang University
Muang, Chiangrai, 57100, Thailand
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 8, 2026
First Posted
February 13, 2026
Study Start
February 9, 2026
Primary Completion (Estimated)
February 8, 2027
Study Completion (Estimated)
February 8, 2027
Last Updated
February 13, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share